Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q4 2025 value amounting to -$4.9 million.

  • Prestige Consumer Healthcare's Other Working Capital Changes fell 17408.24% to -$4.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.8 million, marking a year-over-year increase of 1522549.02%. This contributed to the annual value of -$4.7 million for FY2025, which is 15667.15% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Other Working Capital Changes stood at -$4.9 million for Q4 2025, which was down 17408.24% from $821000.0 recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Other Working Capital Changes ranged from a high of $10.9 million in Q2 2025 and a low of -$7.1 million during Q1 2022
  • Its 5-year average for Other Working Capital Changes is $340400.0, with a median of -$1.1 million in 2022.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 76087.57% in 2021, then tumbled by 1654186.05% in 2022.
  • Prestige Consumer Healthcare's Other Working Capital Changes (Quarter) stood at $6.1 million in 2021, then crashed by 114.85% to -$905000.0 in 2022, then tumbled by 33.59% to -$1.2 million in 2023, then tumbled by 46.48% to -$1.8 million in 2024, then crashed by 174.08% to -$4.9 million in 2025.
  • Its Other Working Capital Changes was -$4.9 million in Q4 2025, compared to $821000.0 in Q3 2025 and $10.9 million in Q2 2025.